Stem cell-based models and therapies for neurodegenerative diseases
Shilpa Iyer1, Khaled Alsayegh, Sheena Abraham
1Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
Critical Reviews in Biomedical Engineering
|June 10, 2010
Summary
Pluripotent stem cells offer a promising alternative to traditional models for studying neurodegenerative diseases. These models aid in understanding neuronal cell death and developing new therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Neurodegenerative disorders cause irreversible neuronal damage, posing a significant healthcare burden.
- Current research is limited by the lack of predictive and relevant human neuron cell models.
- Understanding the genesis of neuronal death, potentially linked to mitochondrial dysfunction, remains a challenge.
Purpose of the Study:
- To highlight the limitations of existing models in neurodegenerative disease research.
- To propose pluripotent stem cells and neural progenitors as superior in vitro models.
- To discuss the potential of cell- and gene-based therapeutics.
Main Methods:
- Utilizing pluripotent stem cells and neural progenitors as in vitro models.
- Assessing stem cells, neural progenitors, and engineered adult cells.
- Investigating the role of mitochondrial dysfunction in neuronal death.
Main Results:
- Pluripotent stem cells offer unlimited proliferation and plasticity for generating diverse neuronal types.
- These stem cells provide a readily available source for studying neurodegenerative cell biology.
- The models facilitate analysis of therapeutic and cytotoxic effects of various agents.
Conclusions:
- Pluripotent stem cells and neural progenitors represent a valuable alternative to traditional cell cultures for neurodegenerative disease research.
- These models can provide crucial insights into neuronal development and disease processes.
- Combined cell- and gene-based therapies hold potential for treating neurodegenerative disorders.
Related Concept Videos
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

